CCEL Stock Analysis: Buy, Sell, or Hold?
CCEL - Cryo-Cell International Inc.
$4.56
0.38 (9.09%)
▲
5d:
+15.15%
30d:
+30.29%
90d:
+30.66%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Jul 21, 2026
0d
Get Alerted When CCEL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: CCEL is 16.3% above its trading range ($3.92). Market expects 8.6% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: CCEL is 16.3% above its trading range ($3.92). Market expects 8.6% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: CCEL is currently trading at $4.56, which is considered extended relative to its 30-day fair value range of $3.35 to $3.92. From a valuation perspective, the stock is trading at a premium (Forward PE: 228.0) compared to its historical average (177.9). At these levels, the market is pricing in 8.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CCEL is showing sideways momentum. Immediate support is located at $3.13, while resistance sits at $4.90. The stock is showing strong short-term momentum, up 9.1% recently.
Market Sentiment: CCEL scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.50 (+86.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CCEL is showing sideways momentum. Immediate support is located at $3.13, while resistance sits at $4.90. The stock is showing strong short-term momentum, up 9.1% recently.
Market Sentiment: CCEL scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.50 (+86.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.35 -
$3.92
Company Quality Score
37/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
22.9%
All Signals
- BEARISH: Price significantly overextended (+16.3% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+9.1%)
- BULLISH: Trading 86.4% below Wall St target ($8.50)
- NEUTRAL: Trading at premium valuation - market expects 8.6% growth which is achievable
- WARNING: Composite score 37/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.35 -
$3.92
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.13
Resistance Level
$4.90
Current Trend
Sideways
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
228.00
Wall Street Target
$8.50
(+86.4%)
Revenue Growth (YoY)
-1.9%
Earnings Growth (YoY)
72.1%
Profit Margin
-7.9%
Valuation Premium vs History
+8.6% premium
PE vs Historical
228.0 vs 177.9
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+8.6%
(market-implied from PE analysis)
1-Year Target
$4.95
(+9%)
2-Year Target
$5.38
(+18%)
3-Year Target
$5.84
(+28%)
3-Yr Target (if PE normalizes)
(PE: 228→178)
PE COMPRESSION
$4.56
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 228.0, Growth: -81.8%)
$3.32
(+-27%)
Base:
(SPY PE: 20.1, Growth: -81.8%)
$0.29
(-94%)
Bear:
(PE: 17.1, Growth: -81.8%)
$0.25
(-95%)
Share & Embed Analysis
Last updated: August 23, 2026 3:08 AM ET
Data refreshes hourly during market hours. Next update: 4:08 AM
Data refreshes hourly during market hours. Next update: 4:08 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CCEL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$282 | 37 SELL |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$455 | 44 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 47 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 42 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$135 | 54 HOLD |
